Navigation Links
Some Fats Deserve Change of Heart
Date:5/30/2008

Survey finds less than half of Americans know two particular fats boost cardiovascular health

FRIDAY, May 30 (HealthDay News) -- Fewer than half of Americans realize there are two types of dietary fat that actually help their hearts, a new survey shows.

So, while many have heeded the warnings about the cardiovascular dangers of trans fats and saturated fats, the American Heart Association (AHA) now thinks people need to pay more attention to the cardiovascular benefits conferred by polyunsaturated and monounsaturated fats.

As a result of its recent survey, the AHA's new Face the Fats campaign has harnessed the power of the Internet to encourage people to view these lesser known fats with new respect.

"We're trying to take education to the next level and say when you have the opportunity to choose, choose the better fat, not the bad fat," said Dr. Clyde W. Yancy, the association's president-elect.

The campaign's Web page presents information at varying levels of sophistication. The pages include an interactive quiz on fats, menus, recipes and a Fats 101 course. A Fats Translator calculates a body-mass index from the input of height, weight, age and level of activity. The index is a scale ranging from under weight to obesity.

The AHA decided to go digital in this phase of its campaign because "the Web really is becoming the world's premier information source, so we have to be there," Yancy added.

"When we have lots of polyunsaturated and monounsaturated fats in our diet, our HDL cholesterol goes up and helps protect our arteries from clogging up and hardening," explained Lona Sandon, an assistant professor of clinical nutrition at the University of Texas Southwestern. "HDL kind of acts like a broom and sweeps up the artery-damaging molecules and takes them away."

Trans fats and saturated fats are more able to stick to blood vessel walls and harden arteries, Yancy added.
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. End-stage dementia patients deserve the same access to palliative care as people with cancer
2. New Yorkers Deserve Access to Spiritually Based Healing
3. Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Childrens Health Care?
4. Delisting Notification Received from the American Stock Exchange
5. KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings
6. China Sky One Medical, Inc. Commences Trading on the American Stock Exchange
7. China Sky One Medical, Inc. Approved for Listing on the American Stock Exchange
8. Lifestyle Changes Can Keep Diabetes at Bay for 14 Years
9. Sponsor of Drug Bill Rejected by CA Senate Today Changed Its Name After Privacy Violations
10. Lilly Announces Changes in Key Leadership Roles
11. Hologic Announces Organizational Change
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Some Fats Deserve Change of Heart 
Some Fats Deserve Change of Heart
(Date:12/7/2009)... -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: ... St. George,s Hospital, University of London during a ... ("ASH") Annual Meeting updated results from the pivotal ... pixantrone (the "PIX 301 EXTEND trial") in relapsed ... who have failed 2 or more prior therapies. ...
(Date:12/6/2009)... ORLEANS and SUNNYVALE, Calif., Dec. 6 ... interim results from a Phase I/II study showing ... / recurrent non-Hodgkin,s Lymphoma (NHL) treated with its ... data were presented today at the 51st ASH ... (Abstract # 2726). ,, PCI-24781 is an ...
(Date:12/6/2009)... of feline DNA in virus , , SUNDAY, Dec. 6 (HealthDay ... might be found in a tiger that lived thousands or ... appears the virus took on a bit of a tiger,s ... remains in the virus to this day. That tiger, in ... of the virus that ultimately led to its infection of ...
(Date:12/6/2009)... Hamilton, ON. Dec. 6, 2009 A new study ... disorder known as venous thromboembolism (VTE). , The ... Americans every year, and occurs when an abnormal clot ... blood, causing pain and swelling. In some cases, the ... travel through the heart to the lungs, causing a ...
(Date:12/5/2009)... ORLEANS, Dec. 5 There have been significant scientific ... experts continue to gain a better understanding of how ... options and provide patients with the best care. Research ... American Society of Hematology explores optimal induction therapies for ...
Breaking Medicine News(10 mins):Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:AIDS May Date Back to Ancient Tiger 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8
... pulmonary arterial hypertension (PAH)chronically high blood pressure in the ... low (called hyponatremia, or HN) have a very poor ... failure (RHF), according to new research from the University ... known to indicate advanced left heart failure but has ...
... of Lower Manhattan, the terrorist attacks of September 11, ... by the Health Department,s World Trade Center Health Registry, ... had posttraumatic stress disorder (PTSD) two to three years ... residents developed PTSD at three times the usual rate ...
... Valuable Patient Care,Resources in Manner True to Their Mission, ... from Los Angeles and Orange Counties demonstrated in front ... Thursday, June 12th to protest the,firm,s anti-union tactics aimed ... System (SJHS), a $3.4 billion dollar corporation,founded by the ...
... Bipartisan Package Would Have Improved Benefits for Prevention, ... CHICAGO, June 12 Today a minority ... and improve Medicare,for the 44 million Americans who ... Providers Act, which would have improved Medicare,s,prevention, mental ...
... A University of Alberta researcher in collaboration with researchers ... come with age, at least when it comes to ... Dolcos, assistant professor of psychiatry and neuroscience in the ... help healthy older people regulate and control emotion better ...
... (NYSE: GRB ), a worldwide leader in integrated ... investors on,Thursday, June 19, 2008, at 10:00 a.m. (Eastern ... financial results and provide a Company,update. The Company will ... and full year on June 19, 2008 before the ...
Other Medicine News:Health News:Serum sodium predicts mortality 10 times higher in PAH patients 2Health News:1 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9/11 2Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 2Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 3Health News:AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill 2Health News:AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill 3Health News:New research shows how aging brain brings a healthy dose of perspective 2Health News:Gerber Scientific to Hold Fiscal Year 2008 Fourth Quarter and Full Year Conference Call 2
(Date:12/4/2009)... $2.8 million, four-year federal grant will support researchers at ... collaborators at Wake Forest University as they study why ... and how to address the problem. This "storage lesion," ... risk for cardiovascular events and organ failure, particularly among ...
(Date:12/4/2009)... Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, ... related amended Disclosure Statement with the United States Bankruptcy Court ... to consider the adequacy of the Disclosure Statement is presently ... confirmation of the Plan scheduled for January 7, 2010. ,, ...
(Date:12/4/2009)... (OTC Bulletin Board: OXBT) today announced that the first ... dose escalation, clinical trial in Switzerland for use of ... the Company,s perfluorocarbon (PFC) therapeutic oxygen carrier. ,, "This ... of patients with severe TBI. We hope to finally ...
Breaking Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2UCI researchers create new strategy for highly selective chemotherapy delivery 58290 1UCI researchers create new strategy for highly selective chemotherapy delivery 58290 2Siebel Foundation awards top UC San Diego bioengineering graduate students 10098 1Siebel Foundation awards top UC San Diego bioengineering graduate students 10098 2Siebel Foundation awards top UC San Diego bioengineering graduate students 10098 3Siebel Foundation awards top UC San Diego bioengineering graduate students 10098 4Nanoparticle based battlefield pain treatment moves a step closer 10094 1Nanoparticle based battlefield pain treatment moves a step closer 10094 2
... WIRE)--July 8, 2007 - Cougar Biotechnology,Inc. (OTCBB:CGRB) today ... on the Company's prostate cancer drug candidate CB7630,(abiraterone ... Oncology (ESMO) Conference, which is currently taking place,in ... oral and,poster presentations on Sunday, July 8, as ...
... Positive Phase IIa Clinical,Trial Results, First clinical ... in AM-Pharma's Pipeline , BUNNIK, The Netherlands, ... novel therapeutics to treat,infectious and inflammatory diseases, ... Phase IIa Alkaline Phosphatase (AP) trial,for patients ...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 6AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
... Para 12 Plus is a hematology control ... 3500/3700. Assay values are provided for the ... a three-part differential on the CELL-DYN 1600 ... and closed-vial stability is 75 days. Para ...
Indicated to facilitate the intra-luminal placement of conventional guidewires beyond stenotic lesions, including chronic total coronary occlusions....
... 5X is a whole blood hematology control ... 80 and 120, and the Coulter AcT5diff ... a unique white cell differential, positioning the ... on the systems. The product offers 105-day ...
Medicine Products: